Many women risk their own health for the sake of their loved ones, according to research.

Two-thirds of women surveyed by the British Heart Foundation said they were more concerned about the health of family and friends than their own

Danielle George - All Headline News Staff Reporter

Danielle M

The American Urological Association invented a medicine named dapoxetine to help men tackle premature ejaculation playing a spoilsport in their sex lives. The medicine has been unveiled at an annual meeting of the association on Monday.

The scientists of the American Urological Association claimed that men suffering from premature ejaculation are increasing in number

A recent study at The OregonHealth and Science University has shown that a potentform of Vitamin D may help men dying of prostatecancer extend their lives by upwards of seven months.The study considered men who had advanced tumorsgrowing despite having undergone surgery, radiation orsubsequent drug treatments. In such cases, patientsare given the chemotherapy drug, docetaxel. When the experimental vitamin DN-101 was taken withthe chemotherapy, patients increased their expectancyrates by roughly two years.A two-year survival "is the highest ever seen in arandomized study," said Dr. Bruce Montgomery, aSeattle Cancer Care Alliance prostate cancer expertwho was not involved in the research. "It clearly is abig step forward."Researchers know DN-101 adds at least seven months tothe average survival rate, but they can't yetcalculate the new median life expectancy because halfthe men who took the vitamin for the study are stillalive.The treatment "has a lot of guys I see every daygetting a meaningful chunk of extra time, without anyextra side effect," said Dr. Tomasz Beer, the OHSUCancer Institute scientist who helped develop thedrug.The study folllowed 250 men who were randonly assignedto receive docetaxel alone or along with DN-101. Themedian survival rate of those who took the chemo drugalone was 16.4 months. An additional 7.1 monthsminimum was added to those who combined the chemo andthe vitamin.Beer says the study is big enough to indicate thepills extend life, but it is not big enough to proveDN-101 is market-ready."That will take a study with about 600 men," he added.According to the AP, if DN-101 makes it to market,OHSU stands to profit. The university licensed thedrug to Novacea in 2002, getting payments includingstock in the privately held company and royalties onany sales of the drug

McDonald's announces its implementation of a new, healthier blend of oil being used to cook their french fries in a small number of undisclosed restaurant locations.

The company has chosen not to reveal how many and which restaurants are using the new cooking oil. McDonald's spokesman, Walt Riker, says they are gauging customer feedback but wouldn't say what the response has been. "We're continuing to test in a small number of restaurants. It's important for our customers and we'll continue to test to get it right